ALAGE DYNAMICS CORP PROVIDES CORPORATE UPDATE

TORONTO, CANADA / October 1, 2015 / ALGAE DYNAMICS CORP (OTC:ADYNF) (the "Company"), is a development stage company focused on the commercialization of its proprietary BioSilo® cultivation system for the growth of algae strains for use in the food and health supplement industry, is issuing this press release to provide a corporate update.

The following are some of the key milestones that position the Company for future development:

  • Production facility in Mississauga, Ontario fully built-out and clean room ready for delivery of production scale cultivation vessels;
  • Equipment fully sourced and ready to order, subject available financing;
  • Trading symbol obtained stock listed on OTCmarkets.com as an OTC Pink stock trading under the ticker symbol "ADYNF";
  • Full-service eligibility with both DTC (Depository Trust Company) in the United States and CDS (Canadian Depository for Stocks); and

Paul Ramsay, Chairman and President of the Company said, "We are pleased to provide this timely update on our business. As we continue to work with scientists at the University of Waterloo, including Dr. Kirsten Muller, one of the world's leading phycologists, we now have the essential elements in place with which to execute our business plan. We expect developments to escalate quite rapidly."

About Algae Dynamics Corp

ADC is currently engaged in the commercialization of our proprietary BioSilo® algae cultivation system for the high volume, low cost production of pure contaminant-free algae biomass. This biomass is high in Omega-3s DHA/DPA, vitamins, minerals and antioxidants, all of which are in demand by the growing multibillion dollar food/beverage and health care sectors. Our integrated BioSilo® manufacturing system provides low cost algae biomass production with modest capital cost requirements compared to conventional approaches. Furthermore, our "controlled outcomes" technology provides ultra-high purity algae biomass, differentiating it from other producers in the market. Following completion of a commercial-scale production facility we intend to produce algae biomass for sale into the functional additive and supplement markets, focusing on Chlorella and Omega-3 oil.

NOTE REGARDING FORWARD-LOOKING STATEMENTS

This news release contains "forward-looking statements" as that term is defined in Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, use of proceeds and the development, costs and results of current or future actions and opportunities in the sector. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies, our ability to raise the additional funding we will need to continue to pursue our exploration and development program, and our ability to retain important members of our management team and attract other qualified personnel. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K for the most recent fiscal year, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

FOR MORE INFORMATION, PLEASE CONTACT:

Craig Redding
Triumph Investor Relations
Phone: 772-345-5861
Email: credding@triumphinvestorrelations.com